Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen.
Lai, Kunbei
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen. [electronic resource] - BMC ophthalmology Jun 2018 - 144 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1471-2415
10.1186/s12886-018-0801-7 doi
Angiogenesis Inhibitors--administration & dosage
Choroid--blood supply
Choroid Diseases--diagnosis
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Intravitreal Injections
Male
Middle Aged
Photochemotherapy--methods
Photosensitizing Agents--therapeutic use
Polyps--diagnosis
Porphyrins--therapeutic use
Prospective Studies
Ranibizumab--administration & dosage
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Verteporfin
Visual Acuity
Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen. [electronic resource] - BMC ophthalmology Jun 2018 - 144 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
1471-2415
10.1186/s12886-018-0801-7 doi
Angiogenesis Inhibitors--administration & dosage
Choroid--blood supply
Choroid Diseases--diagnosis
Dose-Response Relationship, Drug
Drug Therapy, Combination
Female
Fluorescein Angiography
Follow-Up Studies
Fundus Oculi
Humans
Intravitreal Injections
Male
Middle Aged
Photochemotherapy--methods
Photosensitizing Agents--therapeutic use
Polyps--diagnosis
Porphyrins--therapeutic use
Prospective Studies
Ranibizumab--administration & dosage
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Verteporfin
Visual Acuity